You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Prudent rate hikes, stronger mortgage market and higher reinvestment rate, partly offset by significant catastrophe losses, are likely to have influenced the second-quarter performances of LNC, MET, AFG, RDN and MTG.
Medical Device players are expected to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how MCK, FMS and GKOS are likely to have performed this time.
With oil price being lower year over year, the overall energy business scenario is likely to have been hurt. Let's see how Marathon (MRO), Williams (WMB) & Sunoco (SUN) are placed ahead of Q2 earnings.
Improved premiums resulting from rate increases are expected to have driven the Q2 performance of ALL, AFL, AIG, PRU and UNM. An active catastrophe environment is likely to have dented growth prospects.